120
Views
4
CrossRef citations to date
0
Altmetric
Articles

Flow Cytometry Characterization of Pluripotent Transmembrane Glycoproteins on Resident Cervix Uteri Cells in Patients Screened for Cervical Cancer

, , ORCID Icon, , ORCID Icon, ORCID Icon, , & ORCID Icon show all
Pages 228-239 | Received 06 Nov 2019, Accepted 09 Mar 2020, Published online: 13 Apr 2020
 

Abstract

The aim of this study was to characterize both by flow cytometry analysis and immunohistochemistry cervix uteri cells of nulliparous women screened for cervical intraepithelial neoplasia (CIN) in comparison to a group without CIN by using mesenchymal stem cell-like and hematopoietic lineage markers. A significant expression for CD29, CD38, HLA-I, and HLA-II was correlated positively to the CIN degree and it was more relevant in patients positive for human papilloma virus (HPV). Thus, identification and detailed characterization of pluripotent resident in uteri cells could be a promising therapeutic target.

Acknowledgments

The authors thank Dr. Amelia Casamassimi for initial determination of experimental conditions of uteri samples collection.

Declaration of interest

The authors have no conflicts of interest to disclose.

Additional information

Funding

This work was supported by research institutional funds from Chair of Gynecology, University of Campania “L. Vanvitelli” (Prof. N. Colacurci) and Immunohistochemistry laboratory of Federico II University of Naples (Dr. G. Mansueto).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.